UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

139: Radical re-irradiation for localised recurrence in lung cancer patients – A single centre experience

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S62-S63

2017

Volltextzugriff (PDF)

Long-term Overall Survival Outcomes in Patients with Early Stage, Peripherally Located, Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy in a Non-academic Cancer Centre

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-05, Vol.33 (5), p.283-291

2021

Volltextzugriff (PDF)

Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

Annals of oncology, 2018-10, Vol.29, p.viii729-viii730

2018

Volltextzugriff (PDF)

EP-1212: Are the encouraging SABR results for NSCLC reproducible outside of pioneering academic institutions?

Radiotherapy and oncology, 2016-04, Vol.119, p.S574-S575

2016

Volltextzugriff (PDF)

119P SURVIVAL ANALYSIS IN PATIENTS WITH MALIGNANT AIRWAY STENOSIS REFERRED FOR ENDOBRONCHIAL INTERVENTION AND SUBSEQUENT ANTI-CANCER TREATMENT

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S52-S52

2013

Volltextzugriff (PDF)

128: Experience of lung stereotactic ablative body radiotherapy (SABR) in a non-academic cancer centre in the UK

Lung cancer (Amsterdam, Netherlands), 2015, Vol.87, p.S46-S47

2015

Volltextzugriff (PDF)

57 Crizotinib in clinical practice: the North East of England's experience

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S21-S21

2016

Volltextzugriff (PDF)

72: Audit of outcomes of NSCLC patients treated with first line EGFR inhibitors in North East England

Lung cancer (Amsterdam, Netherlands), 2015, Vol.87, p.S28-S28

2015

Volltextzugriff (PDF)

178 Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable NSCLC: initial outcomes from 3 years experience at James Cook University Hospital (JCUH), Middlesbrough

Lung cancer (Amsterdam, Netherlands), 2013, Vol.79, p.S61-S61

2013

Volltextzugriff (PDF)

A regional experience of advanced, non-squamous, ALK positive patients: their treatment and outcomes

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.S60

2020

Volltextzugriff (PDF)

SBRT of Liver and Lung Metastasis with the Next Generation of Tomotherapy

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S829-S829

2010

Volltextzugriff (PDF)

Adjuvant chemotherapy for non-small cell lung cancer: The need for a further trial in the context of the new (seventh) TNM staging system for Lung and Pleura

Lung cancer (Amsterdam, Netherlands), 2010, Vol.67, p.S16-S16

2010

Volltextzugriff (PDF)

Audit of outcomes of patients with stage III NSCLC (TNM VII) who were treated with radical RT or high-dose palliative radiotherapy between January 2017 and July 2017

Lung cancer (Amsterdam, Netherlands), 2019-01, Vol.127, p.S79-S79

2019

Volltextzugriff (PDF)

The experience of immunotherapy in lung cancer: an audit of immunotherapy use as second-line treatment for metastatic non-small cell lung cancer (NSCLC) in the South Tees region

Lung cancer (Amsterdam, Netherlands), 2019-01, Vol.127, p.S43-S43

2019

Volltextzugriff (PDF)

The experience of immunotherapy in lung cancer: an audit of patients receiving first-line immunotherapy for metastatic small cell lung cancer in South Tees between June 2016 and December 2017

Lung cancer (Amsterdam, Netherlands), 2019-01, Vol.127, p.S43-S43

2019

Volltextzugriff (PDF)

19 Audit of adjuvant chemotherapy for non small cell lung carcinoma

Lung cancer (Amsterdam, Netherlands), 2007, Vol.57, p.S6-S6

2007

Volltextzugriff (PDF)

OC-0533 Two Centre Feasibility study of single fraction lung stereotactic ablative radiotherapy (SABR)

Radiotherapy and oncology, 2021-08, Vol.161, p.S420-S421

2021

Volltextzugriff (PDF)

PO-0988: Is there a learning curve for SABR that affects overall survival outcomes in early stage NSCLC?

Radiotherapy and oncology, 2020-11, Vol.152, p.S526-S526

2020

Volltextzugriff (PDF)

Stereotactic ablative radiotherapy for early stage, medically inoperable NSCLC – outcomes from a single non-academic centre in the UK

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.S61

2018

Volltextzugriff (PDF)

144 - Stereotactic ablative radiotherapy for early stage, medically inoperable NSCLC – outcomes from a single non-academic centre in the UK

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.S61-S61

2018

Volltextzugriff (PDF)

LBA9_PRCetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Outcomes of a Series of 237 Patients with Early Stage Peripheral NSCLC, Treated by SABR in a Single Institution Non-academic Setting

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-06, Vol.30 (6), p.e55-e56

2018

Volltextzugriff (PDF)

Hospital admissions for chemotherapy-related toxicity in patients with metastatic breast cancer as negative quality-of-life index at Wansbeck Hospital, Northumberland

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e11523-e11523

2010

Volltextzugriff (PDF)

A Combined Conductivity—Temperature Probe for Use up to 3000°K

Measurement and control (London), 1968-08, Vol.1 (8), p.285-286

Aynsley, E.

1968

Volltextzugriff (PDF)

598. The preparation and properties of tellurium dichloride

Journal of the Chemical Society, 1953, p.3016

Aynsley, E. E.

1953

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(147)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(60)
Life Sciences & Biomedicine
(56)
Female
(31)
Biological And Medical Sciences
(27)
Male
(24)
Medical Sciences
(24)
Infant, Newborn
(20)
Pediatrics
(19)
Infant
(17)
Child
(16)
Adolescent
(15)
Child, Preschool
(15)
Endocrinology & Metabolism
(13)
Hematology, Oncology And Palliative Medicine
(10)
Insulin - Metabolism
(10)
Adult
(9)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Animals
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

139: Radical re-irradiation for localised recurrence in lung cancer patients – A single centre experience

Long-term Overall Survival Outcomes in Patients with Early Stage, Peripherally Located, Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy in a Non-academic Cancer Centre

Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

EP-1212: Are the encouraging SABR results for NSCLC reproducible outside of pioneering academic institutions?

119P SURVIVAL ANALYSIS IN PATIENTS WITH MALIGNANT AIRWAY STENOSIS REFERRED FOR ENDOBRONCHIAL INTERVENTION AND SUBSEQUENT ANTI-CANCER TREATMENT

128: Experience of lung stereotactic ablative body radiotherapy (SABR) in a non-academic cancer centre in the UK

57 Crizotinib in clinical practice: the North East of England's experience

72: Audit of outcomes of NSCLC patients treated with first line EGFR inhibitors in North East England

178 Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable NSCLC: initial outcomes from 3 years experience at James Cook University Hospital (JCUH), Middlesbrough

A regional experience of advanced, non-squamous, ALK positive patients: their treatment and outcomes

SBRT of Liver and Lung Metastasis with the Next Generation of Tomotherapy

Adjuvant chemotherapy for non-small cell lung cancer: The need for a further trial in the context of the new (seventh) TNM staging system for Lung and Pleura

Audit of outcomes of patients with stage III NSCLC (TNM VII) who were treated with radical RT or high-dose palliative radiotherapy between January 2017 and July 2017

The experience of immunotherapy in lung cancer: an audit of immunotherapy use as second-line treatment for metastatic non-small cell lung cancer (NSCLC) in the South Tees region

The experience of immunotherapy in lung cancer: an audit of patients receiving first-line immunotherapy for metastatic small cell lung cancer in South Tees between June 2016 and December 2017

19 Audit of adjuvant chemotherapy for non small cell lung carcinoma

OC-0533 Two Centre Feasibility study of single fraction lung stereotactic ablative radiotherapy (SABR)

PO-0988: Is there a learning curve for SABR that affects overall survival outcomes in early stage NSCLC?

Stereotactic ablative radiotherapy for early stage, medically inoperable NSCLC – outcomes from a single non-academic centre in the UK

144 - Stereotactic ablative radiotherapy for early stage, medically inoperable NSCLC – outcomes from a single non-academic centre in the UK

LBA9_PRCetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

Outcomes of a Series of 237 Patients with Early Stage Peripheral NSCLC, Treated by SABR in a Single Institution Non-academic Setting

Hospital admissions for chemotherapy-related toxicity in patients with metastatic breast cancer as negative quality-of-life index at Wansbeck Hospital, Northumberland

A Combined Conductivity—Temperature Probe for Use up to 3000°K

598. The preparation and properties of tellurium dichloride

Suchergebnisse filtern